Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

What is the purpose of this trial?

This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.


Participation Guidelines

Ages: 18 years and older

Gender: Both


Allergan Sales, Inc.

Start Date: 02/28/2017

End Date: 08/31/2016

Last Updated: 02/22/2018

Study HIC#: 1507016115

Get Involved

For more information about this study, contact:
Kristine Tyc
+1 203-737-4697
kristine.tyc@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Ji Liu

Principal Investigator

Sub-Investigators